Indo Amines Intrinsic Value

INDOAMIN • Chemicals

Indo Amines (INDOAMIN) median intrinsic value is ₹120.00 from 10 valuation models (range ₹32–₹213), vs current price ₹106.52 — +12.7% upside (Trading Below Median Value), margin of safety 11.2%. For current market price and key ratios, visit INDOAMIN stock price BSE.

Current Stock Price
₹106.52
Primary Intrinsic Value
₹120.00
Market Cap
₹383.5 Cr
+12.7% Upside
Median Value
₹120.00
Value Range
₹32 - ₹213
Assessment
Trading Below Median Value
Safety Margin
11.2%

INDOAMIN Valuation Methods Summary — DCF, Graham Number & P/E

Indo Amines intrinsic value across 10 models vs current price ₹106.52 — upside/downside and value range per method. Browse INDOAMIN balance sheet details for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹120.00 ₹96.00 - ₹144.00 +12.7% EPS: ₹10.00, Sector P/E: 12x
Book Value Method asset ₹88.33 ₹79.50 - ₹97.16 -17.1% Book Value/Share: ₹88.33, P/B: 1.0x
Revenue Multiple Method revenue ₹213.04 ₹191.74 - ₹234.34 +100.0% Revenue/Share: ₹313.33, P/S: 0.8x
EBITDA Multiple Method earnings ₹213.04 ₹191.74 - ₹234.34 +100.0% EBITDA: ₹148.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹90.26 ₹72.21 - ₹108.31 -15.3% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹64.00 ₹57.60 - ₹70.40 -39.9% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹82.40 ₹74.16 - ₹90.64 -22.6% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹213.04 ₹191.74 - ₹234.34 +100.0% ROE: 22.6%, P/E Multiple: 16x
Graham Defensive Method conservative ₹140.98 ₹126.88 - ₹155.08 +32.4% EPS: ₹10.00, BVPS: ₹88.33
Dividend Yield Method dividend ₹31.96 ₹28.76 - ₹35.16 -70.0% DPS: ₹0.50, Target Yield: 3.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

INDOAMIN Intrinsic Value vs Market Price — All Valuation Models

Indo Amines fair value range ₹32–₹213 vs current market price ₹106.52 across 10 valuation models. Compare with INDOAMIN stock valuation models to assess whether the stock is under or overvalued.

INDOAMIN Intrinsic Value Analysis — Undervalued or Overvalued?

Indo Amines median intrinsic value ₹120.00, current price ₹106.52 — Trading Below Median Value by 12.7%, margin of safety 11.2%.

What is the intrinsic value of INDOAMIN?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Indo Amines (INDOAMIN) is ₹120.00 (median value). With the current market price of ₹106.52, this represents a +12.7% variance from our estimated fair value.

The valuation range spans from ₹31.96 to ₹213.04, indicating ₹31.96 - ₹213.04.

Is INDOAMIN undervalued or overvalued?

Based on our multi-method analysis, Indo Amines (INDOAMIN) appears to be trading below median value by approximately 12.7%.

INDOAMIN Financial Health — Key Ratios vs Industry Benchmarks

Indo Amines financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 5.29 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 2.45 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 22.6% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 12.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.45x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

INDOAMIN Cash Flow Quality — Operating & Free Cash Flow

Indo Amines operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹35 Cr ₹-6 Cr Positive Operating Cash Flow 6/10
March 2024 ₹70 Cr ₹57 Cr Positive Free Cash Flow 8/10
March 2023 ₹20 Cr ₹5 Cr Positive Free Cash Flow 7/10
March 2022 ₹16 Cr ₹-4 Cr Positive Operating Cash Flow 6/10
March 2021 ₹56 Cr ₹31 Cr Positive Free Cash Flow 8/10